IUSTI-Europe Statement on HIV Pre-exposure Prophylaxis Provision – Key Steps for Clinicians
Europe and near Asia are facing different problems with controlling the HIV epidemic. In making this statement IUSTI- Europe wishes to identify the important steps governments, agencies, healthcare providers and individuals can take to promote the availability, accessibility and take up of Pre-exposure prophylaxis (PrEP) against HIV. Although these have been clearly articulated in the WHO PrEP Guidance and the review of PrEP provision that the ECDC has recently issued we consider it important that clinicians recognise the urgency with which this needs to be undertaken.
Read more:
IUSTI-Europe Statement (English)
IUSTI-Europe Webinars
The series of IUSTI-Europe Webinars will be continued in 2023.
Meanwhile watch the recordings of the IUSTI-Europe Webinars.
See you soon!
Dr. Derek Freedman & Prof. George-Sorin Tiplica
Webinar coordinators
Mpox multi-country outbreak
Over 61000 cases from 111 countries have been reported to WHO by 24 April 2023.
To keep up to date with the situation and response here are some useful links:
- WHO situation reports
- ECDC Mpox pages: factsheets, Q&A, resource sheets and epidemiology
- ECDC Public Health considerations for mpox
- BASHH UK monkeypox resource pages have lots of useful operational guidance
- Advice on Risk Communication and Community Engagement from ECDC
Dr. Andrew Winter
IUSTI-Europe Communications
Statement on the conflict in Ukraine
IUSTI-Europe Statement on the conflict in Ukraine
(27 February, 2022)